• Nenhum resultado encontrado

[PDF] Top 20 The prognostic role of mTOR and p-mTOR for survival in non-small cell lung cancer: a systematic review and meta-analysis.

Has 10000 "The prognostic role of mTOR and p-mTOR for survival in non-small cell lung cancer: a systematic review and meta-analysis." found on our website. Below are the top 20 most common "The prognostic role of mTOR and p-mTOR for survival in non-small cell lung cancer: a systematic review and meta-analysis.".

The prognostic role of mTOR and p-mTOR for survival in non-small cell lung cancer: a systematic review and meta-analysis.

The prognostic role of mTOR and p-mTOR for survival in non-small cell lung cancer: a systematic review and meta-analysis.

... existed in this meta-analysis should also be presented. First, the number of studies involved was relatively small, especially studies about mTOR ...stratifying ... See full document

13

Lymphangiogenic Markers and Their Impact on Nodal Metastasis and Survival in Non-Small Cell Lung Cancer--A Structured Review with Meta-Analysis.

Lymphangiogenic Markers and Their Impact on Nodal Metastasis and Survival in Non-Small Cell Lung Cancer--A Structured Review with Meta-Analysis.

... be of interest for future studies ...tumor cell migration to lymph nodes only can occur in functional lymphatic vessels mostly found in the tumor periphery and not in ... See full document

17

Role of survival post-progression in phase III trials of systemic chemotherapy in advanced non-small-cell lung cancer: a systematic review.

Role of survival post-progression in phase III trials of systemic chemotherapy in advanced non-small-cell lung cancer: a systematic review.

... regression analysis for SPP was conducted to clarify which clinical factors could affect SPP (Table ...3). The year of trial initiation was a significant factor (regression coefficient of ... See full document

8

Prognostic Value of Basic Fibroblast Growth Factor (bFGF) in Lung Cancer: A Systematic Review with Meta-Analysis.

Prognostic Value of Basic Fibroblast Growth Factor (bFGF) in Lung Cancer: A Systematic Review with Meta-Analysis.

... is the formation of new blood vessels from the endothelium of existing vasculature, plays a pivotal role in tumor growth, progression and metastasis ...series of ... See full document

14

Proportional weight loss in six months as a risk factor for mortality in stage IV non- small cell lung cancer

Proportional weight loss in six months as a risk factor for mortality in stage IV non- small cell lung cancer

... as prognostic markers of 3-month survival after diagnosis of stage IV non-small cell lung cancer ...a cancer treatment center in southern ... See full document

5

The prognostic value of phosphorylated AKT expression in non-small cell lung cancer: a meta-analysis.

The prognostic value of phosphorylated AKT expression in non-small cell lung cancer: a meta-analysis.

... a role in the survival of cancer cells in breast, prostate, ovary, and brain tissue ...promotes survival of NSCLC cell [29]. Recently, a ... See full document

6

Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice

Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice

... vesicles of endolysosomal origin, released by several cytotypes in physiological and pathological ...cells of the tumor microenvironment, modulate tumor progression, angiogenic switch, ... See full document

13

Single-agent maintenance therapy for advanced non-small cell lung cancer (NSCLC): a systematic review and Bayesian network meta-analysis of 26 randomized controlled trials

Single-agent maintenance therapy for advanced non-small cell lung cancer (NSCLC): a systematic review and Bayesian network meta-analysis of 26 randomized controlled trials

... databases and meeting abstracts searches, a total of 1,368 records were ...rounds of assessment, 26 trials covering 7,839 patients met all the inclusion criteria, and comprised ... See full document

24

Analysis of Prognostic Factors in 541 Female Patients with Advanced Non-small Cell Lung Cancer

Analysis of Prognostic Factors in 541 Female Patients with Advanced Non-small Cell Lung Cancer

... Background and objective As there is a sharp increase in the incidence of lung cancer in women in re- cent years, it has brought broad concerns with its unique ... See full document

6

BRCA1: a novel prognostic factor in resected non-small-cell lung cancer.

BRCA1: a novel prognostic factor in resected non-small-cell lung cancer.

... values and ranges were derived for quantitative variables and mRNA gene ...means of absolute frequencies and percentages. The Kruskal- Wallis test was used to check for ...Differences ... See full document

7

THROMBOCYTOSIS AS PROGNOSTIC FACTOR FOR SURVIVAL IN PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER TREATED WITH FIRST- LINE CHEMOTHERAPY.

THROMBOCYTOSIS AS PROGNOSTIC FACTOR FOR SURVIVAL IN PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER TREATED WITH FIRST- LINE CHEMOTHERAPY.

... prevalence of thrombocytosis did not differ sig- nificantly between ages, sex and ...On the contrary, in the present study we identified significant association between elevated ... See full document

5

The prognostic value of BRAF mutation in colorectal cancer and melanoma: a systematic review and meta-analysis.

The prognostic value of BRAF mutation in colorectal cancer and melanoma: a systematic review and meta-analysis.

... especially in melanoma generated a tremendous research effort to block this signaling pathway for cancer ...treatment. The usage of most available multi-kinase inhibitor at that time, ... See full document

10

Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.

Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.

... Subgroup analysis is a method for exploring the sources of heterogeneity and for increasing the reliability of an ...affects the prognosis of NSCLC [39]. While ... See full document

13

Prophylactic cranial irradiation may impose a detrimental effect on overall survival of patients with nonsmall cell lung cancer: a systematic review and meta-analysis.

Prophylactic cranial irradiation may impose a detrimental effect on overall survival of patients with nonsmall cell lung cancer: a systematic review and meta-analysis.

... This meta-analysis provided additional insights into use of PCI in patients with ...NSCLC. The analysis included 12 clinical studies (6 RCTs and 6 nonRCTs), involving a ... See full document

12

Nuclear survivin and its relationship to DNA damage repair genes in non-small cell lung cancer investigated using tissue array.

Nuclear survivin and its relationship to DNA damage repair genes in non-small cell lung cancer investigated using tissue array.

... The prognostic predictive value of survivin expression and that of nuclear staining versus cytoplasmic staining in several malig- nancies, including NSCLC, have been investigated ... See full document

10

Blood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysis.

Blood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysis.

... standardization of evaluating vascular invasion and quality control is needed. In addition, an important issue that needs to be taken into account is the type of adjuvant therapy that ... See full document

8

Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysis.

Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysis.

... target of rapamycin (mTOR)/AKT pathway has been linked to the pathophysiology of several neoplastic diseases ...Activation of this pathway can be a result of mutations in ... See full document

8

Int. braz j urol.  vol.42 número4

Int. braz j urol. vol.42 número4

... supports the involve- ment of systemic inflammation in cancer develop- ment and progression ...by the concentration of acute phase proteins, CRP, fibrinogen, ferritin, ... See full document

7

Potential role of immunotherapy in advanced non-small-cell lung cancer

Potential role of immunotherapy in advanced non-small-cell lung cancer

... redirect and reprogram patient T-cells have shown promising results in the treatment of acute lympho- blastic leukemia and non-Hodgkin’s ...with the ability to target ... See full document

10

Int. braz j urol.  vol.42 número4

Int. braz j urol. vol.42 número4

... In the present study, the number of lym- ph nodes removed in the ELRC group was signifi- cantly lower than the TLRC ...group. The extent of pelvic lymph ... See full document

8

Show all 10000 documents...